RITTER PHARMACEUTICALS INC (59) | Intellectual Property (2)
- Exclusive License Agreement, by and between the Company and University of Louisville Research Foundation, Inc. dated as of June 9, 2020 (Filed With SEC on August 14, 2020)
- Exclusive License Agreement, by and between Qualigen Therapeutics, Inc. and University of Louisville Research Foundation, Inc. dated as of July 17, 2020 (Filed With SEC on August 4, 2020)
